Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01494649 · ClinicalTrials.gov registry record · NA
Pilot Study to Investigate the Efficacy of a Toothpaste in Providing Relief From Dentinal Hypersensitivity
A NA study of Hypersensitivity and Dentinal Sensitivity, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- NA
- Development phase
- 118
- Enrollment target
- 1
- Study location
NCT01494649: Completed NA study of Hypersensitivity and Dentinal Sensitivity, sponsored by GlaxoSmithKline.
NCT01494649 is a NA study of Hypersensitivity and Dentinal Sensitivity that has completed, run by GlaxoSmithKline. The registered enrollment target is 118 participants, below the 170-participant average among 8 other Hypersensitivity trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01494649, a NA study of Hypersensitivity and Dentinal Sensitivity, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- NA
- Development phase
- 118 participants
- Enrollment target
- 1
- Study location
Study Summary
A pilot study to determine the ability of a stannous fluoride containing toothpaste to provide immediate and short term relief from dentine Hypersensitivity compared to a control toothpaste.
Primary Outcome
Response to a constant (duration, pressure, temperature, distance from target) jet of air applied to a hypersensitive tooth was evaluated using Schiff Cold Air Sensitivity Scale. According to this analog scale hypersensitivity scores for the stimulated tooth is 0, 1, 2 or 3 (lower the score, lower the hypersensitivity).0= no response; 1= response and no discontinuation request; 2= response and discontinuation request; 3= painful response and discontinuation request. Change was calculated as Schi
Conditions Studied
Interventions
- DRUG Negative Control Toothpaste
- DRUG Test Toothpaste
Study Locations (1)
Nevada
- BioSci Research America, Inc. - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2011-09 |
| Est. Completion | 2011-09 |
| Phase | NA |
What the finished NCT01494649 record still lists
NCT01494649 is an interventional study that assigns participants to a tested intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, below the 170-participant average among 8 other Hypersensitivity trials with a reported enrollment target (31% lower).
The record links to 2 conditions, with Hypersensitivity appearing as the primary indexed condition, and to 2 interventions - of which Negative Control Toothpaste is the first listed.
NCT01494649 reports a single indexed study location in Nevada.
Frequently Asked Questions
What is clinical trial NCT01494649 about?
NCT01494649 is a clinical study titled "Pilot Study to Investigate the Efficacy of a Toothpaste in Providing Relief From Dentinal Hypersensitivity". A pilot study to determine the ability of a stannous fluoride containing toothpaste to provide immediate and short term relief from dentine Hypersensitivity compared to a control toothpaste.
What is the current status of trial NCT01494649?
This trial is currently completed. It is a NA study. The enrollment target is 118 participants. The study started on 2011-09. Estimated completion is 2011-09.
What conditions does trial NCT01494649 study?
This clinical trial studies the following conditions: Hypersensitivity, Dentinal Sensitivity.
What interventions are being tested in trial NCT01494649?
The interventions under investigation include: Negative Control Toothpaste (DRUG), Test Toothpaste (DRUG).
Who is sponsoring clinical trial NCT01494649?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01494649 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypersensitivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01494649's enrollment target sits among peer trials
118 3rd of 8 higher than 6 of 8 other Hypersensitivity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypersensitivity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hybrid SA RGP Center/S-H Skirt Daily Wear 90 Day Multicenter Study
COMPLETED · NA
-
Asthma Data Innovation Demonstration Project
COMPLETED · NA
-
Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
RECRUITING
-
Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies
COMPLETED · Phase 2
-
Oral Bacteria and Allergic Disease in Children
COMPLETED
-
Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821623 · 118 participants · Phase 2
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- NCT04040959 · 118 participants · Phase 2
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- NCT04696029 · 118 participants · Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- NCT05223192 · 118 participants · NA
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia